Saxenda® is made up of liraglutide and should not be coadministered with other liraglutide-that contains goods or with another GLP-1 receptor agonist The safety and success of Saxenda® in pediatric sufferers with kind two diabetic issues haven't been provendesogestrel decreases effects of liraglutide by pharmacodynamic antagonism. Use Warning/Kee